Freedom Leaf Enters $20 Billion Anti-Cholesterol Market With Acquisition of a Patent Pending Non-Prescription Formula. No FDA ...
While This Formula is Not Hemp Extract-Based, it Fits Perfectly with Our Focus on Health & Wellness, Including Our Ayurvedic Herbal Formulas Las Vegas, NV, June 21, 2018 (GLOBE NEWSWIRE) -- Freedom Leaf, Inc. (OTCQB: FRLF), has acquired the patent …